COMMUNIQUÉS West-GlobeNewswire

Asterias Provides Six Month Data Readout for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury
17/07/2018
- Current Readout Includes New Six Month Data for Cohort 5 and Aggregate Trial Data - - Results Continue to Demonstrate Favorable Safety Profile, Potential for Durable Cell Engraftment at the Injury Site and Improved [...]
Evogene and IMAmt Enter a Collaboration in the Field of Insect Resistance Traits in Cotton
17/07/2018
Evogene will identify candidate toxins mainly against Cotton Boll Weevil and IMAmt will validate the toxins REHOVOT, Israel and CUIABÁ/MT, Brazil, July 17, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN [...]
Resverlogix Announces Upcoming Presentations at Clinical Trials in Alzheimer’s Disease (CTAD) Asia and Alzheimer’s Association International Conference (AAIC)
17/07/2018
CALGARY, Alberta, July 17, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that it has been awarded two presentations at the Clinical Trials in Alzheimer’s Disease ( [...]
BioTelemetry, Inc. to Release Second Quarter 2018 Earnings Results on July 25, 2018
17/07/2018
MALVERN, Pa., July 17, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call [...]
Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimer’s Association International Conference
17/07/2018
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Capricor and USAISR Announce Collaboration to Investigate Exosome Platform to Treat Injured Troops
17/07/2018
Research to Explore Potential for CAP-2003 to Address Trauma-related Injuries LOS ANGELES, July 17, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR) today announced it has entered into an agreement with the [...]
Auxly Congratulates Streaming Partner CannTx Life Sciences on Obtaining Cultivation Licence
17/07/2018
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that Auxly’s streaming partner, CannTx Life Sciences Inc. (“ [...]
APEIRON Appoints Peter Llewellyn-Davies as Chief Executive Officer
17/07/2018
The Former CEO, Dr. Hans Loibner, Will Continue to Support the Company as Senior Advisor VIENNA, Austria, July 17, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer immunotherapy, today [...]
PotNetwork Holdings, Inc., With Sales of Over $10 Million Year-To-Date, Moves Toward Uplisting and Expansion
17/07/2018
FT. LAUDERDALE, Fla., July 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) on July 13 th , the Company announced that it had filed a Form 10 registration statement with the [...]
Transactions in relation to share buyback program
17/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at AAIC in Chicago
17/07/2018
Crenezumab's Second Phase 3 Trial (CREAD 2) Fully Recruited - Updates on AC Immune's Pipeline and Technology Platforms to be presented at the Alzheimer's Association International Conference in Chicago Lausanne, [...]
Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year
17/07/2018
Interim report for Enzymatica AB (publ) JANUARY-JUNE 2018 Lower sales in Q2 but 31% increase for the first half of the year Q2 Net sales reached SEK 5.3 (5.9) million. Net profit after tax came in at SEK -15.5 (-10.8) [...]
CellaVision AB: Interim Report January-June 2018
17/07/2018
Good sales growth in all regions April 1-June 30, 2018 Net sales increased by 17% to SEK 91.9 million (78.7). Organic growth was 15%. Operating profit was SEK 31.6 million (24.6). Operating margin was 34.4% (31.3). [...]
Terveystalo Plc: The Finnish Competition and Consumer Authority initiates further proceedings concerning the transaction between Terveystalo and Attendo
17/07/2018
Terveystalo Plc Stock Exchange release 17 July 2018 at 09.00 a.m. EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo [...]
Shire plc : Rule 2.9 Announcement
17/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 17 July 2018 Shire [...]
Nicox : Point d'activité et résumé financier du second trimestre 2018
17/07/2018
Communiqué de presse Nicox : Point d'activité et résumé financier du second trimestre 2018 .............................................. 17 juillet 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]
Nicox Second Quarter 2018 Business Update and Financial Highlights
17/07/2018
Press Release Nicox Second Quarter 2018 Business Update and Financial Highlights .............................................. July 17, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
argenx receives milestone payment from strategic collaboration with Shire
17/07/2018
July 17, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Biocartis Group NV: Biocartis launches innovative Idylla(TM) MSI Assay
17/07/2018
PRESS RELEASE : 17 July 2018, 07:00 CEST Biocartis launches innovative Idylla(TM) MSI Assay Idylla(TM) MSI Assay further strengthens Biocartis' test menu and offers opportunities to enter the immuno-oncology testing [...]

Pages